This is a press release talking about Dr. James Berenson and the clinic that he heads The Institute for Myeloma and Bone Cancer Research (IMBCR), citing the mean life expectancy quoted by the ACS as 3-5 years compared to the mean life expectancy of his patients of 9.75 years. The press release talks about "breakthrough research" done at the clinic.

Does anyone know what, if any, breakthrough research being done at the IMBCR?  Is Dr. Berenson doing anything different that other mm centers?  David